Effect of Interferon-Alpha, Ribavirin, Pentoxifylline, and Interleukin-18 Antibody on Hepatitis C Sera-Stimulated Hepatic Stellate Cell Proliferation

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Interferon and Cytokine Research

• Publication date

  2008-10-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1089/jir.2007.0123PMID 18844579
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C

  2008cited by this paper
• A novel drug interaction between the quinolone antibiotic ciprofloxacin and a chiral metabolite of pentoxifylline.

  2007cited by this paper
• Effect of fetuin, a TGFbeta antagonist and pentoxifylline, a cytokine antagonist on hepatic stellate cell function and fibrotic parameters in fibrosis.

  2007cited by this paper
• Up-regulation of IL-18 by interferon alpha-2b/ribavirin combination therapy induces an anti-viral effect in patients with chronic hepatitis C.

  2005cited by this paper
• Viral hepatitis C.

  2004cited by this paper
• Extrinsic allergic alveolitis: inhibitory effects of pentoxifylline on cytokine production by alveolar macrophages.

  2004cited by this paper
• A Pilot Trial of Pentoxifylline in Nonalcoholic Steatohepatitis

  2004cited by this paper
• Role of CYP1A2 and CYP2E1 in the pentoxifylline ciprofloxacin drug interaction.

  2004cited by this paper
• Depressive Symptoms after Initiation of Interferon Therapy in Human Immunodeficiency Virus-Infected Patients with Chronic Hepatitis C

  2004cited by this paper
• Effects of pentoxifylline on the hepatic content of TGF-beta1 and collagen in Schistosomiasis japonica mice with liver fibrosis.

  2003cited by this paper
• A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodimers.

  2003cited by this paper
• Liver fibrosis -- from bench to bedside.

  2003influential reference
• Ribavirin inhibits DNA, RNA, and protein synthesis in PHA‐stimulated human peripheral blood mononuclear cells: Possible explanation for therapeutic efficacy in patients with chronic HCV infection

  2003cited by this paper
• Differential requirements for JAK2 and TYK2 in T cell proliferation and IFN‐γ production induced by IL‐12 alone or together with IL‐18

  2003cited by this paper
• Chronic hepatitis C.

  2003cited by this paper
• Viral hepatitis C.

  2003cited by this paper
• Molecular basis of hepatic fibrosis

  2003cited by this paper
• Production of interleukin‐18 and interleukin‐12 in patients suffering from chronic hepatitis C virus infection before antiviral therapy

  2003cited by this paper
• Effects of pentoxifylline on the hepatic content of TGF-β1 and collagen in Schistosomiasis japonica mice with liver fibrosis

  2003cited by this paper
• Kinetics of serum cytokines reflect changes in the severity of chronic hepatitis C presenting minimal fibrosis

  2002cited by this paper
• Selective down-regulation of c-jun gene expression by pentoxifylline and c-jun antisense interrupts platelet-derived growth factor signaling: pentoxifylline inhibits phosphorylation of c-Jun on serine 73.

  2002cited by this paper
• Interferon-alpha induces interleukin-18 binding protein in chronic hepatitis C patients.

  2002cited by this paper
• Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C.

  2002cited by this paper
• Mechanism of action of ribavirin in the combination treatment of chronic HCV infection

  2002cited by this paper
• Interferon‐α induces interleukin‐18 binding protein in chronic hepatitis C patients

  2002cited by this paper
• Pentoxifylline downregulates profibrogenic cytokines and procollagen I expression in rat secondary biliary fibrosis

  2002cited by this paper
• Serum gamma‐interferon‐inducing factor (IL‐18) and IL‐10 levels in patients with acute hepatitis and fulminant hepatic failure

  2002cited by this paper
• Effects of antidepressant drugs on the activity of cytochrome P-450 measured by caffeine oxidation in rat liver microsomes.

  2001cited by this paper
• Hepatitis C virus infection.

  2001cited by this paper
• Hepatic Stellate Cells as a Target for the Treatment of Liver Fibrosis

  2001cited by this paper
• Effects of pentoxifylline, pentifylline and gamma-interferon on proliferation, differentiation, and matrix synthesis of human renal fibroblasts.

  2000cited by this paper
• Platelet-derived growth factor and pentoxifylline modulation of collagen synthesis in myofibroblasts.

  1998influential reference
• Interleukin-18: perspectives on the newest interleukin.

  1998cited by this paper
• Effect of acute pentoxifylline treatment in an experimental model of colitis

  1997influential reference
• IL-18 accounts for both TNF-alpha- and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice.

  1997cited by this paper
• Elevated serum aminoterminal procollagen type-III-peptide parallels collagen accumulation in rats with secondary biliary fibrosis.

  1996cited by this paper
• Aminoterminal propeptide of type III procollagen: a marker of hepatic fibrosis after bile duct obstruction in the monkey.

  1996cited by this paper
• Inhibition of fibroproliferation by pentoxifylline. Activity of metabolite-1 and lack of role of adenosine receptors.

  1996cited by this paper
• Effect of pentoxifylline on the fibrogenic functions of cultured rat liver fat-storing cells and myofibroblasts.

  1996cited by this paper
• Cloning of a new cytokine that induces IFN-gamma production by T cells.

  1995cited by this paper
• Cloning of a new cytokine that induces IFN-γ production by T cells

  1995cited by this paper
• Pentoxifylline prevents fibrosis in an animal model and inhibits platelet‐derived growth factor–driven proliferation of fibroblasts

  1993cited by this paper
• Identification and partial characterization of a hepatocyte‐derived factor promoting proliferation of cultured fat‐storing cells (parasinusoidal lipocytes)

  1992cited by this paper
• Jun is phosphorylated by several protein kinases at the same sites that are modified in serum-stimulated fibroblasts

  1992cited by this paper
• Collagen peptidase and type III procollagen peptide serum levels in chronic liver diseases.

  1991cited by this paper
• The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation.

  1991influential reference
• Expression of the gene of the α-smooth muscle-actin isoform in rat liver and in rat fat-storing (ITO) cells

  1990cited by this paper
• Pentoxifylline inhibits normal human dermal fibroblast in vitro proliferation, collagen, glycosaminoglycan, and fibronectin production, and increases collagenase activity.

  1989cited by this paper
• Pentoxifylline

  1987cited by this paper
• Purified Rat Liver Fat‐Storing Cells in Culture Divide and Contain Collagen

  1984cited by this paper

• A Historical Overview on the Role of Hepatitis B and C Viruses as Aetiological Factors for Hepatocellular Carcinoma

  2023cites this paper
• Multi‐faceted role of pyroptosis mediated by inflammasome in liver fibrosis

  2022cites this paper
• Assessment of Pyroptosis-Related Indicators as Potential Biomarkers and Their Association with Severity in Patients with Liver Cirrhosis

  2021cites this paper
• The Role of Viruses in Carcinogenesis and Molecular Targeting: From Infection to Being a Component of the Tumor Microenvironment

  2021cites this paper
• Hepatic stellate cells – from past till present: morphology, human markers, human cell lines, behavior in normal and liver pathology

  2021cites this paper
• Role of hepatic stellate cell (HSC)-derived cytokines in hepatic inflammation and immunity.

  2019cites this paper
• Viral hepatitis and hepatocellular carcinoma: etiology and management.

  2017cites this paper
• Knockdown of Fstl1 attenuates hepatic stellate cell activation through the TGF‑β1/Smad3 signaling pathway.

  2017cites this paper
• Viral Oncology: Molecular Biology and Pathogenesis

  2017cites this paper
• Inflammasome activation and function in liver disease

  2015cites this paper
• Safety, tolerability, pharmacokinetics, and pharmacodynamics of single-dose antiinterleukin- 18 mAb GSK1070806 in healthy and obese subjects.

  2014cites this paper
• WITHDRAWN: Evaluation of correlation between serum immunoglobulin levels and extent of hepatic fibrosis in patients with chronic B and C hepatitis

  2013cites this paper
• Role of JNK Signalling and AHR in Fibrosis, Implications for New

  2013influential citation
• Interference with ERK and STAT signaling pathways and inhibition of hepatitis C virus replication by ribavirin.

  2012cites this paper
• Cholangiocarcinoma: A cancer in search of the right classification

  2012cites this paper
• The Role of Interferon Therapy in Patients with Hepatocellular Carcinoma

  2012cites this paper
• Pancreatic and Hepatic Fibrosis: Remarkable Similarities

  2012cites this paper
• Ribavirin and Interferon Alter Mmp-9 Abundance In Vitro and in HIV–HCV-Coinfected Patients

  2011cites this paper
• The effect of pentoxifylline and its metabolite-1 on inflammation and fibrosis in the TNBS model of colitis.

  2011cites this paper
• Cocktail therapy with a combination of interferon, ribavirin and angiotensin-II type 1 receptor blocker attenuates murine liver fibrosis development.

  2011cites this paper
• Effects of interleukin-18 on cardiac fibroblast function and gene expression.

  2011cites this paper
• Antiviral therapy for hepatitis C is associated with improved clinical outcomes in patients with advanced fibrosis

  2010cites this paper
• Erratum to: The Role of Interferon Therapy in Patients With Hepatocellular Carcinoma

  2009cites this paper